Proton Pump Inhibitors and Hypomagnesemia in the General Population: A Population-Based Cohort Study

American Journal of Kidney Diseases

Volumn 66, Issue 5, 2015, Pages 775-782

  Kieboom, Brenda C T ^a,b   Kiefte De Jong, Jessica C ^a,c   Eijgelsheim, Mark ^a   Franco, Oscar H ^a   Kuipers, Ernst J ^a   Hofman, Albert ^a   Zietse, Robert ^a   Stricker, Bruno H ^a,b   Hoorn, Ewout J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Netherlands Health Care Inspectorate   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

acid suppressive medication; diuretics; drug safety; Epidemiology; histamine 2 receptor antagonist (H2RA); hypomagnesemia; intestinal magnesium loss; magnesium; population based cohort; proton pump inhibitor (PPI); Rotterdam Study; TRPM6

Indexed keywords

DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; LOOP DIURETIC AGENT; MAGNESIUM; PROTON PUMP INHIBITOR;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPOMAGNESEMIA; KIDNEY FUNCTION; MAGNESIUM BLOOD LEVEL; MAGNESIUM INTAKE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK; BLOOD; COMPARATIVE STUDY; DIET; MULTIVARIATE ANALYSIS; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; WATER-ELECTROLYTE IMBALANCE;

COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIET; HISTAMINE H2 ANTAGONISTS; LINEAR MODELS; MAGNESIUM; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; RISK FACTORS; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; WATER-ELECTROLYTE IMBALANCE;

EID: 84945493670     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.05.012     Document Type: Article

References (37)

1. M.W. Hess, J.G. Hoenderop, R.J. Bindels, and J.P. Drenth Systematic review: hypomagnesaemia induced by proton pump inhibition Aliment Pharmacol Ther 36 5 2012 405 413
2. I. Koulouridis, M. Alfayez, H. Tighiouart, and et al. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study Am J Kidney Dis 62 4 2013 730 737
3. M. Epstein, S. McGrath, and F. Law Proton-pump inhibitors and hypomagnesemic hypoparathyroidism N Engl J Med 355 17 2006 1834 1836
4. E.J. Hoorn, J. van der Hoek, R.A. de Man, E.J. Kuipers, C. Bolwerk, and R. Zietse A case series of proton pump inhibitor-induced hypomagnesemia Am J Kidney Dis 56 1 2010 112 116
5. W.H. Kao, A.R. Folsom, F.J. Nieto, J.P. Mo, R.L. Watson, and F.L. Brancati Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study Arch Intern Med 159 18 1999 2151 2159
6. T.S. Orchard, J.C. Larson, N. Alghothani, and et al. Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study Am J Clin Nutr 99 4 2014 926 933
7. A.M. Khan, S.A. Lubitz, L.M. Sullivan, and et al. Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study Circulation 127 1 2013 33 38
8. L.C. Del Gobbo, F. Imamura, J.H. Wu, M.C. de Oliveira Otto, S.E. Chiuve, and D. Mozaffarian Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies Am J Clin Nutr 98 1 2013 160 173
9. G. Liamis, E.M. Rodenburg, A. Hofman, R. Zietse, B.H. Stricker, and E.J. Hoorn Electrolyte disorders in community subjects: prevalence and risk factors Am J Med 126 3 2013 256 263
10. N. Markovits, R. Loebstein, H. Halkin, and et al. The association of proton pump inhibitors and hypomagnesemia in the community setting J Clin Pharmacol 54 8 2014 889 895
11. J. Danziger, J.H. William, D.J. Scott, and et al. Proton-pump inhibitor use is associated with low serum magnesium concentrations Kidney Int 83 4 2013 692 699
12. G.A. Faulhaber, B.M. Ascoli, A. Lubini, and et al. Serum magnesium and proton-pump inhibitors use: a cross-sectional study Rev Assoc Med Bras 59 3 2013 276 279
13. G. Lindner, G.C. Funk, A.B. Leichtle, and et al. Impact of proton pump inhibitor use on magnesium homoeostasis: a cross-sectional study in a tertiary emergency department Int J Clin Pract 68 11 2014 1352 1357
14. J.T. Gau, Y.X. Yang, R. Chen, and T.C. Kao Uses of proton pump inhibitors and hypomagnesemia Pharmacoepidemiol Drug Saf 21 5 2012 553 559
15. J. Zipursky, E.M. Macdonald, S. Hollands, and et al. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study PLoS Med 11 9 2014 e1001736
16. A. Hofman, S. Darwish Murad, C.M. van Duijn, and et al. The Rotterdam Study: 2014 objectives and design update Eur J Epidemiol 28 11 2013 889 926
17. A. Hofman, M.M. Breteler, C.M. van Duijn, and et al. The Rotterdam Study: objectives and design update Eur J Epidemiol 22 11 2007 819 829
18. World Health Organization. ATC/DDD Index. 2014. http://www.whocc.no/atc-ddd-index/. Accessed June 9, 2015.
19. K. Klipstein-Grobusch, J.H. den Breeijen, R.A. Goldbohm, and et al. Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire Eur J Clin Nutr 52 8 1998 588 596
20. R.A. Goldbohm, P.A. van den Brandt, H.A. Brants, and et al. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer Eur J Clin Nutr 48 4 1994 253 265
21. G.I. Feunekes, W.A. Van Staveren, J.H. De Vries, J. Burema, and J.G. Hautvast Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol Am J Clin Nutr 58 4 1993 489 496
22. RIVM (Rijksinstituut van Volksgezondheid en Milieu/National Institute for Public Health and the environment), Nederlands Voedingsstoffenbestand (NEVO)/Dutch Food Composition Table, The Hague, the Netherlands. 2006. http://rivm.nl/Onderwerpen/N/Nederlands-Voedingsstoffenbestand. Accessed June 9, 2015.
23. W.C. Willett, G.R. Howe, and L.H. Kushi Adjustment for total energy intake in epidemiologic studies Am J Clin Nutr 65 4 1997 1220S 1228S
24. A.S. Levey, L.A. Stevens, C.H. Schmid, and et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
25. A.P. Dempster, N.M. Laird, and D.B. Rubin Maximum likelihood from incomplete data via em algorithm J R Stat Soc Series B Methodol 39 1 1977 1 38
26. T. Cundy, and A. Dissanayake Severe hypomagnesaemia in long-term users of proton-pump inhibitors Clin Endocrinol (Oxf) 69 2 2008 338 341
27. G. Famularo, L. Gasbarrone, and G. Minisola Hypomagnesemia and proton-pump inhibitors Expert Opin Drug Saf 12 5 2013 709 716
28. C. Serfaty-Lacrosniere, R.J. Wood, D. Voytko, and et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans J Am Coll Nutr 14 4 1995 364 368
29. J.P. Bai, E. Hausman, R. Lionberger, and X. Zhang Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium Mol Pharm 9 12 2012 3495 3505
30. M.T. Kuipers, H.D. Thang, and A.B. Arntzenius Hypomagnesaemia due to use of proton pump inhibitors - a review Neth J Med 67 5 2009 169 172
31. J.D. Mackay, and P.T. Bladon Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series QJM 103 6 2010 387 395
32. 2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia J Clin Invest 115 6 2005 1651 1658
33. M.J. Moore Thiazide-induced hypomagnesemia [letter] JAMA 240 12 1978 1241
34. D.H. Ellison, H. Velazquez, and F.S. Wright Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion J Clin Invest 83 1 1989 113 126
35. A.L. Lameris, M.W. Hess, I. van Kruijsbergen, J.G. Hoenderop, and R.J. Bindels Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6 Pflugers Arch 465 11 2013 1613 1620
36. US Food and Drug Administration. FDA Drug Safety Communication: low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs). http://www.fda.gov/drugs/drugsafety/ucm245011.htm. Accessed November 20, 2014.
37. T. Cundy, and J. Mackay Proton pump inhibitors and severe hypomagnesaemia Curr Opin Gastroenterol 27 2 2011 180 185